Adam D. Kennedy

7.0k total citations · 1 hit paper
65 papers, 5.0k citations indexed

About

Adam D. Kennedy is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Adam D. Kennedy has authored 65 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 22 papers in Clinical Biochemistry and 16 papers in Physiology. Recurrent topics in Adam D. Kennedy's work include Metabolomics and Mass Spectrometry Studies (19 papers), Metabolism and Genetic Disorders (18 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Adam D. Kennedy is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (19 papers), Metabolism and Genetic Disorders (18 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Adam D. Kennedy collaborates with scholars based in United States, United Kingdom and Canada. Adam D. Kennedy's co-authors include Frank R. DeLeo, Kevin R. Braughton, Ronald P. Taylor, Michaël Otto, Margaret A. Lindorfer, Paul V. Beum, Adeline R. Whitney, David W. Dorward, Sarah H. Elsea and Michael E. Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Blood.

In The Last Decade

Adam D. Kennedy

61 papers receiving 4.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA

2007 817 citations Rong Wang, Kevin R. Braughton et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam D. Kennedy United States	36	2.6k	1.7k	1.1k	853	534	65	5.0k
Karen M. Frank United States	33	3.0k 1.2×	559 0.3×	528 0.5×	395 0.5×	228 0.4×	73	4.7k
Shaoguang Wu United States	28	3.6k 1.4×	1.3k 0.8×	708 0.6×	324 0.4×	364 0.7×	54	5.4k
Tasuke Konno Japan	24	1.5k 0.6×	841 0.5×	1.3k 1.1×	216 0.3×	256 0.5×	128	4.4k
Naoki Watanabe Japan	28	1.2k 0.5×	661 0.4×	584 0.5×	230 0.3×	130 0.2×	142	2.8k
Ing‐Marie Jonsson Sweden	29	1.4k 0.5×	670 0.4×	913 0.8×	307 0.4×	148 0.3×	47	2.8k
John L. Ryan United States	33	1.6k 0.6×	684 0.4×	2.5k 2.2×	120 0.1×	267 0.5×	92	5.6k
Gabriel Virella United States	41	1.2k 0.5×	297 0.2×	2.4k 2.1×	528 0.6×	366 0.7×	222	5.8k
Sanna M. Goyert United States	43	1.5k 0.6×	475 0.3×	4.6k 4.1×	167 0.2×	446 0.8×	85	6.8k
Karl Köhrer Germany	35	2.1k 0.8×	608 0.3×	487 0.4×	233 0.3×	245 0.5×	167	4.3k
Christine Tkaczyk United States	35	1.3k 0.5×	860 0.5×	2.2k 1.9×	94 0.1×	771 1.4×	66	3.8k

Countries citing papers authored by Adam D. Kennedy

Since Specialization

Citations

This map shows the geographic impact of Adam D. Kennedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam D. Kennedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam D. Kennedy more than expected).

Fields of papers citing papers by Adam D. Kennedy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam D. Kennedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam D. Kennedy. The network helps show where Adam D. Kennedy may publish in the future.

Co-authorship network of co-authors of Adam D. Kennedy

This figure shows the co-authorship network connecting the top 25 collaborators of Adam D. Kennedy. A scholar is included among the top collaborators of Adam D. Kennedy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam D. Kennedy. Adam D. Kennedy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, Marcus J., Adam D. Kennedy, Rebecca McClellan, et al.. (2025). The emerging role of metabolomics analysis in genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 27(10). 101493–101493.

Reinson, Karit, Kai Muru, Tiia Reimand, et al.. (2025). Exploratory analysis of epilepsy biomarkers using untargeted metabolomics across multiple cohorts. Frontiers in Neurology. 16. 1684456–1684456.

Niu, Zhigao, Lasse Ingerslev Blaabjerg, Henrik D. Pedersen, et al.. (2024). Salcaprozate-based ionic liquids for GLP-1 gastric delivery: A mechanistic understanding of in vivo performance. Journal of Controlled Release. 377. 267–276. 4 indexed citations

Kennedy, Adam D., Karen L. DeBalsi, Sarah H. Elsea, et al.. (2024). Integrating Genome Sequencing and Untargeted Metabolomics in Monozygotic Twins with a Rare Complex Neurological Disorder. Metabolites. 14(3). 152–152. 2 indexed citations

Kennedy, Adam D., Lisa A. Ford, Bryan M. Wittmann, et al.. (2021). Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives. PLoS ONE. 16(4). e0249797–e0249797. 19 indexed citations

Ford, Lisa A., Adam D. Kennedy, Kelli D. Goodman, et al.. (2020). Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism. The Journal of Applied Laboratory Medicine. 5(2). 342–356. 116 indexed citations

Burrage, Lindsay C., Bridget M. Stroup, Qin Sun, et al.. (2019). Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders. Genetics in Medicine. 21(9). 1977–1986. 46 indexed citations

Bainbridge, Matthew N., Erin Cooney, Marcus J. Miller, et al.. (2017). Analyses of SLC13A5 -epilepsy patients reveal perturbations of TCA cycle. Molecular Genetics and Metabolism. 121(4). 314–319. 47 indexed citations

Pappan, Kirk L., Adam D. Kennedy, Pilar Magoulas, et al.. (2017). Clinical Metabolomics to Segregate Aromatic Amino Acid Decarboxylase Deficiency From Drug-Induced Metabolite Elevations. Pediatric Neurology. 75. 66–72. 19 indexed citations

10.

Kennedy, Adam D., Marcus J. Miller, Kirk Beebe, et al.. (2016). Metabolomic Profiling of Human Urine as a Screen for Multiple Inborn Errors of Metabolism. Genetic Testing and Molecular Biomarkers. 20(9). 485–495. 42 indexed citations

11.

Porter, Adeline R., et al.. (2014). Phagocytosis and Killing of <b><i>Staphylococcus aureus</i></b> by Human Neutrophils. Journal of Innate Immunity. 6(5). 639–649. 57 indexed citations

12.

DeLeo, Frank R., Adam D. Kennedy, Liang Chen, et al.. (2011). Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proceedings of the National Academy of Sciences. 108(44). 18091–18096. 120 indexed citations

13.

Kobayashi, Scott D., Kevin R. Braughton, Amy M. Palazzolo‐Ballance, et al.. (2010). Rapid Neutrophil Destruction following Phagocytosis of Staphylococcus aureus. Journal of Innate Immunity. 2(6). 560–575. 133 indexed citations

14.

Kennedy, Adam D., Michaël Otto, Kevin R. Braughton, et al.. (2008). Epidemic community-associated methicillin-resistant Staphylococcus aureus : Recent clonal expansion and diversification. Proceedings of the National Academy of Sciences. 105(4). 1327–1332. 300 indexed citations

15.

Wang, Rong, Kevin R. Braughton, Dorothee Kretschmer, et al.. (2007). Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nature Medicine. 13(12). 1510–1514. 817 indexed citations breakdown →

16.

Williams, Michael E., John Densmore, Andrew W. Pawluczkowycz, et al.. (2006). Thrice-Weekly Low-Dose Rituximab Decreases CD20 Loss via Shaving and Promotes Enhanced Targeting in Chronic Lymphocytic Leukemia. The Journal of Immunology. 177(10). 7435–7443. 124 indexed citations

17.

Beum, Paul V., Adam D. Kennedy, Michael E. Williams, Margaret A. Lindorfer, & Ronald P. Taylor. (2006). The Shaving Reaction: Rituximab/CD20 Complexes Are Removed from Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Cells by THP-1 Monocytes. The Journal of Immunology. 176(4). 2600–2609. 168 indexed citations

18.

Kennedy, Adam D., Paul V. Beum, Michael D. Solga, et al.. (2004). Rituximab Infusion Promotes Rapid Complement Depletion and Acute CD20 Loss in Chronic Lymphocytic Leukemia. The Journal of Immunology. 172(5). 3280–3288. 276 indexed citations

19.

Lindorfer, Margaret A., et al.. (2003). B Cell Complement Receptor 2 Transfer Reaction. The Journal of Immunology. 170(7). 3671–3678. 28 indexed citations

20.

Kennedy, Adam D., Michael D. Solga, Theodore A. Schuman, et al.. (2003). An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab. Blood. 101(3). 1071–1079. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact